Endeavor

Many Lymphoma Patients Missing Out on Best Care

Study shows survival drops when CAR T therapy is not offered to eligible patients

A Mystery Rash, a Diagnosis Delayed

Larry Hart sought answers for years before cutaneous T-cell lymphoma landed him in the ICU

Navigating Survivorship After Bone and Marrow Transplant

Moffitt experts and leukemia survivor share candid insights and support resources

6 Questions With an Occupational Therapist

Moffitt occupational therapist explains how they help patients return to daily activities.

Pickleball Keeps Cancer Survivors on Their Toes, Moffitt Study Shows

Partnership program with YMCA motivated survivors to increase activity, connect with others

Advocating for Patients From Bench to Bedside

Through education, research and advocacy, these women faculty ensure patient experience guides cancer care

Can a Ketogenic Diet Boost Effectiveness of Cancer Immunotherapy?

Study finds that a compound from ketosis helps fuel the CAR T cells, making them more effective at attacking cancer

Hard-to-Treat Lymphoma Patients Benefit From New Immunotherapy

AZD0486 demonstrates high response rates in relapsed/refractory diffuse large B-cell lymphoma, including patients who failed CAR-T therapy

New Treatment Combination Improves Outcomes for Relapsed or Refractory Large B-Cell Lymphoma

Patients who received the mosunetuzumab-polatuzumab combination had a 78% response rate